@article{JTD19421,
author = {Andreas H. Scheel and Stephan C. Schäfer},
title = {Current PD-L1 immunohistochemistry for non-small cell lung cancer},
journal = {Journal of Thoracic Disease},
volume = {10},
number = {3},
year = {2018},
keywords = {},
abstract = {Immunotherapy that targets PD-1 or PD-L1 by monoclonal antibodies has emerged as effective and safe new treatment of malignant tumours. It is most beneficial in highly immunogenic tumours, in particular in malignant melanoma (1) and in non-small cell lung cancer (NSCLC) (2). Immunohistochemistry (IHC) of PD-L1 protein may serve as predictive biomarker for both PD-1 and PD-L1 inhibitors.},
issn = {2077-6624}, url = {https://jtd.amegroups.org/article/view/19421}
}